Chemotherapy is one of the most effective ways to fight cancer, but the toxic medicine can cause collateral damage to healthy tissue. UC Irvine’s Kenneth Longmuir, physiology & biophysics associate professor (pictured left), and Richard Robertson, anatomy & neurobiology professor, believe they have developed a way for these drugs to reach specific tumors with increased precision, thereby limiting side effects. In a study appearing online in the International Journal of Pharmaceutics, the researchers show that doxorubicin — commonly used to treat a number of cancers — can be directed almost entirely to a particular spot in the body with virtually no spread to other organs. “This promising approach opens up a new avenue to helping people survive cancer,” Longmuir says.   More »